Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX6BM1
|
||||
Drug Name |
SID85736001
|
||||
Synonyms |
CHEMBL567785
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C15H15ClN6
|
||||
Canonical SMILES |
Clc1cccc(Nc2nc(NC3CCCC3)nc(n2)C#N)c1
|
||||
InChI |
InChI=1S/C15H15ClN6/c16-10-4-3-7-12(8-10)19-15-21-13(9-17)20-14(22-15)18-11-5-1-2-6-11/h3-4,7-8,11H,1-2,5-6H2,(H2,18,19,20,21,22)
|
||||
InChIKey |
QNUYHZAYXDMWMT-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.